Flow Cytometry – News and Features

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

Traditional bone marrow aspirate (BMA) stem cell extraction methods are complex, time-consuming, and yield poor results due to antiquated centrifugation techniques.

A recent discovery, published in PLoS Genetics, challenges the “rulebook” of DNA. We speak with the first author, Dr. Jamie McGowan, to learn about the accidental finding and what it means for synthetic biology.

Researchers have unpicked the mechanism behind how Kaposi's sarcoma herpesvirus reprograms immune cells, increasing inflammation and making an individual vulnerable to cancer development.

Research into a series of footprints discovered in White Sands National Park has provided further evidence on the timeline of human activity in the Americas.

Understanding the lipidome provides more details about human physiology, including aging, insulin resistance and viral infection.

Dr. Andreas Boehmler explores how the arrival of new flow cytometry platforms finally puts powerful automation within reach for many labs, allowing operators to enumerate stem cells more quickly and accurately for transplant.

A powerful imaging mass cytometry technique has been used for the first time to examine the kidneys of people with lupus, which could help identify drug targets and novel disease markers.

Researcher publishes a study identifying 135 previously unknown pigmentation genes with broad implications for human diversity, cell biology and medicine.

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.